(From the Laboratories of The Rockefeller Institute for Medical Research)
(Received for publication, February 24, 1936) The virus of equine encephalomyelitis appears in the blood in the natural infection of horses before the appearance of clinical symptoms, and epidemiological and experimental findings favor the view that it is disseminated by insect vectors (1) , especially the mosquito (2-4).
Were immunization attempted by the use of active virus, the danger might arise of bringing about either lethal encephalitis, or blood infection in animals showing no clinical symptoms, thus producing in both instances suitable conditions for insect transmission of the disease. Hence an effective method of immunization without employing active virus would be clearly advantageous.
We regarded the possibility of immunizing animals with this virus, almost or completely inactivated by chemical means, with considerable skepticism in view of the number of failures thus far reported with other viruses. They had yielded results that were not hopeful, or at best inconclusive.
Early attempts were made with virus treated with phenol, glycerol containing phenol, chloroform, saponin, merthiolate, tannic acid, and aluminum hydroxide (5, 6) . These procedures proved unsatisfactory because either inactivation could not be obtained or the antigenic powers of the treated virus were reduced below the desired degree. In our hands, however, the use of formalin gave more promise. After these studies were begun, an article appeared by Shahan and Giltner (7) in which was described the successful immunization of horses, both in the laboratory and in the field, with virus inactivated by 0.4 per cent formalin. Of over 400 horses, each given two doses of 25 cc. of the vaccine, none developed disease. After 6 to 16 weeks, of thir-745 teen vaccinated animals receiving an intralingual test dose that induced disease in all of thirteen controls, nine withstood the inoculation. Howitt, on the other hand (6) , recorded inconclusive results in guinea pigs treated with 1 per cent formolized virus. We continued our investigations on formolized virus, and in view of the generally sarisfactory outcome of Shahan and Giltner's earlier experiments (7), we adapted their method, with certain modifications, to our study.
In this paper we present experimental evidence to show first that it is possible to induce in guinea pigs and mice a high degree of resistance against infection by the use of formolized material in which the virus is inactivated, or reduced to an amount well below its ordinary minimal dose for effective immunization (5)3 Secondly, we offer experiments on the mechanism of the induced immunity, especially with respect to the possible activity of any residual or undetected virus present in such preparations.
Materials and Methods
Virus.--The Eastern strain of equine encephalomyelitis (8) , more highly invasire for guinea pigs and mice than the Western, was employed as fresh or glycerolated guinea pig or mouse brain.
Titration of Virus Infectivity.--In the first experiments the maximal infectivity of the virus sample before formolization was not determined. It was noted later that vaccines made in the same way but with virus from different sources manifested unequal immunizing powers. It was inferred that these differences might have been related to quantity of virus in the source material. In later preparations it was therefore titrated before adding formalin. To titrate, the method of intracerebral injection of anesthetized mice was employed as already described (5) . A noteworthy point is that hormone broth pH 7.4 was used as diluent in titrations since repeated observations have shown that saline solution as a diluent reduces the end-point of activity of fresh or dried virus 10 to 100-fold. In addition, l In the first paper of this series (5) it was found that 3,000 to 30,000 mouse infective units of untreated, active virus (m.i.u.) injected subcutaneously three times at weekly intervals are required to protect guinea pigs against 1,000 or more intracerebral lethal doses and one or two such injections are required to induce resistance against experimental infection by way of the nose or subcutis. Larger quantities, even when given less than three times, are also immunizing but then the incidence of fever, blood infection, and death during the period of immunization increases; and in proportion as the optimal dosage, as mentioned, is decreased, so is the degree of induced immunity diminished.
infected mouse brain per unit weight was found, as a rule, to possess greater infectivity after intracerebral inoculation of mice than guinea pig brain: the limiting infective dilution of the former being ordinarily 0.03 cc. of I0 -v to 10 -s and of guinea pig tissue 0.03 cc. of 10 -s (occasionally I0 -v) dilutions.
Preparation of Vaccine.--Infected mouse or guinea pig brain was ground with sterile sand and 0.85 per cent saline solution to a 20 per cent suspension. This was filtered through at least eight layers of sterile cotton gauze. A portion of the filtrate was removed for titration and to the remainder was added an equal volume of 0.8 to 2 per cent formalin in saline solution. The mixture was kept at room temperature for i to 4 days and then stored at 5°C. for 3 to 65 days until used. Before injecting the vaccine into animals, the formalin was neutralized by ammonium hydroxide against phenolphthalein indicator to avoid toxic reactions.
Procedure of Immunization.--Guinea pigs were injected subcutaneously twice at 5 to 9 days' interval with i cc. each time of the same vaccine. Exceptional dosages will be mentioned in the text. In order to obtain additional evidence of the immunizing capacity of the materials in another host, mice were injected intracerebrally (0.03 cc.) and also intraperitoneally or subcutaneously (0.2 to 0.5 cc.), foUowed after 7 days by a similar intraperitoneal or subcutaneous dose.
Tests for Induced Immunity.--To obviate cross tissue reactions in tests for immunity, guinea pigs received only guinea pig passage virus and mice, mouse passage material. A suitable number of untreated control animals was included in each test and these were injected last to minimize virus deterioration. The immunity tests were given intracerebrally, intranasally, and subcutaneously. The intracerebral inoculation--more drastic, and containing, as a rule, I00 to 1,000 lethal doses--consisted of 0.15 cc. for guinea pigs and 0.03 cc. for mice. Desiccated virus was found to be preferable for this use since its potency could be better controlled. The intranasal test in guinea pigs consisted of an instillation of 0.05 cc. of freshly prepared i0 per cent virus in broth in each nostril, and the subcutaneous test of i cc. of this material. The nasal and cutaneous tests have been discussed in the first paper (5) and ordinarily represent at least I to I0 M.T..D.
Attempts to Find Active Virus in Formolized Preparations.--The
determination, as completely as was possible, of the degree of inactivation of virus in the formalin preparations used for immunization was for the present problem of utmost importance, For one phase of the problem concerned the question of whether protection against experimental infection with formolized material was due to residual active virus or to "killed" virus. All available methods were therefore employed intensively in the search for active virus in the fifteen formol vaccines prepared and employed for immunization. The methods can be classified as follows: (1 The following examples are given of the numerous attempts made to recover active virus from the vaccines.
Method 1.--327 mice and forty guinea pigs received intracerebral and subcutaneous or intraperitoneal injections of undiluted ammonium hydroxide-neutralized vaccines--fourteen being employed in mice and seven in guinea pigs. Mice received 0.03 co. in the brain and 0.2 to 0.5 cc. by the other routes, while guinea pigs were given 0.15 cc. intracerebrally and 1 to 8 cc. subcutaneously or intraperitoneaUy.
Method 2.--54 mice and six guinea pigs were employed in an effort to recover active virus from three of the formol preparations by serial passage in brain tissue, as outlined above.
Method 3.--Twenty-eight anesthetized guinea pigs receiving eleven different vaccines were bled from the heart on the 2nd to the 14th day after intracerebral and subcutaneous injection of vaccine, and each specimen so obtained was tested for virus by intracerebral injection of four mice. Twelve guinea pigs treated similarly with three formolized preparations were killed on the 2nd to 7th day after the vaccine injection and a total of 384 mice were used in the attempt to detect virus in the different organs mentioned, and in the blood. Each of the tissues was ground to an approximate 10 per cent suspension in hormone broth pH 7.6 and after centrifugation at 2,000 g.1,.x¢, for 10 minutes, the supernatant fluid was injected into the brains of four mice.
Method 4.--59 tissue cultures were each inoculated with from 0.5 to 1 cc. of undiluted, formol-neutralized material derived from three different vaccines.
Method 5.--Nine guinea pigs received 0.15 cc. intracerebrally and 1.5 cc. subcutaneously of a formol preparation concentrated fivefold by vacuum distillation and desiccation. One of the animals was killed on the 2nd, another on the 4th, and a third on the 6th day after treatment. In each case the organs as described in Method 3 were tested for the presence of virus by mouse injection.
Method 6.--Eight of the formol vaccines were diluted and over 160 mice were used in these tests.
These tests were considered to be fully sufficient to indicate the presence of virus in the formolized preparations, inasmuch as the quantities put to test were even larger than .the immunizing dose given to animals. The vaccines, thoroughly studied by means of the described methods, showed that thirteen of fifteen failed to yield virus (Tables I and II) . A description of the two materials which contained a barely detectable quantity of virus follows.
Vaccine V, undiluted and diluted 10 -1, 10 -~, 10 ~, and 10 -4, was injected 5 days after its preparation in the brain and peritoneal cavity of a total of 60 mice. Only two of twenty mice receiving the undiluted, and one of ten the 10 -~ dilution developed the lethal virus disease, although after a prolonged incubation period (7 to 8 days). The same vaccine, undiluted, tested 2 days later, showed no virus. With it eight guinea pigs were injected intracerebrally (these animals are equally as reactive as mice after such injection) and also intraperitoneally and subcutaneously with 1.5 to 8 cc. They were unaffected. Of three guinea pigs of the group just cited which received the 8 cc. dosage, one was sacrificed on the 3rd, a second on the 4th, and a third on the 7th day after inoculation, and by means of the mouse intracerebral test, no virus was recovered from their blood or tissues. In addition, three of the remaining five guinea pigs of this group were submitted to an intracerebral test of 1,000 M.L.~. 1 month after the primary inoculation and all survived. We believe that while meagre amounts of active virus were present in this vaccine (V) on the 5th and none on the 7th day after its preparation, yet the substance was highly antigenic. This induced resistance, brought about with what is apparently virus-free material, will be described later.
Vaccine XIII (Table II) . Only one of eighteen mice receiving the undiluted vaccine in the brain and subcutis on the 5th day after its preparation succumbed to virus encephalitis; twenty mice given 10 -1 and 10 -3 dilutions remained well. It is of interest that of four guinea pigs first treated with this vaccine on the day the latter showed the minute amount of virus, all failed to resist from 1,000 to 3,000 Xf.L.D. injected cerebrally 77 days later. The latter observation confirms other data to be presented pointing to the immunizing action of formolized material as being due to some other factor than to residual active virus.
7~0 IMMUNIZATION WITH ENCEPHALOMYELITIS VIRUS. II
Thus two of fifteen formolized vaccines contained barely detectable amounts of virus; one was immunizing; the other not. The one which was antigenic was, interestingly enough, the vaccine that contained no detectable virus at the time of its use in preventive inoculation.
Immunizing Capacity of Formolized Preparations of Virus
It is clear from the foregoing section that the formalin treatment either wholly inactivates the virus or, in exceptional instances, reduces its quantity to a point at which it by itself is not the factor involved in inducing immunity, as was shown in the preceding paper (5) . The question now is whether such material is effective as a vaccine for the production of resistance against infection with the usual test doses. The answer is to be found in the data listed in Table I .
Reference to the table reveals that protection was acquired by 103 of 107 guinea pigs receiving subcutaneous injections of the thirteen different samples of formolized vaccines in which virus could not be detected by the recorded methods. Moreover, the vaccines were kept in the cold up to 65 days and still possessed the capacity to immunize; and the period of acquired resistance endured for at least 92 days--the duration of protection over longer intervals will be described later. The test dose for induced immunity was given either intranasally, subcutaneously, or intracerebrally and in the latter instance consisted, as a rule, of 1,000 M.L.D. or more.
Two of the fifteen formolized preparations were wholly ineffective for immunization (vaccines VII and XIII, Table II) and two were  only partially antigenic (vaccines IV and VIII, Tables I and II) .
Vaccines VII and XIII were prepared from glycerolated material, and one of them (XIII) was already referred to as containing a minimum of active virus at the time of its use. The latter material showed a relatively low titre of 3 X 104 m.i.u, before formolization and the effect of glycerolation on reduction of antigenicity is illustrated by the following experiment.
Vaccine X (effective) was prepared from the fresh, left cerebral hemispheres derived from ten guinea pigs prostrate from the experimental disease, while vaccine XIII (ineffective) was made from the right hemispheres of the same animals but after storage in 50 per cent glycerol for 25 days at 5°C. Storage in glycerol diminished the virus activity in the tissue by about 100 fold.
No titrations were made with the materials entering into the composition of vaccine VII. 
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In vaccine IV the usual technique was modified without good results (Table II) , while vaccine VIII was only partially effective; its virus content was not determined prior to formolization.
It would appear, therefore, that the method of preparation of the vaccines is significant. We may state that within our experience up to the present time fresh (not glycerolated), infected brain tissue derived from mice 3 and guinea pigs, and tissue having a high content of active virus before formolization, should be used preferably.
Duration of Induced Immunity.--As shown in Table III , twelve of thirteen guinea pigs survived an intracerebral test of 1,000 M.L.D. at least, given from 80 to 92 days after the last injection, or from 87 to 99 days after the first treatment. The only animal that succumbed to the test was one of three receiving one immunizing dose. The indication is that two injections of the vaccine are more effective than one, as will be shown again later (see also Tables III, IV, and V). Table III presents results which refer to the duration of resistance over relatively shorter periods of time than those given in Table IV . It will be noted from the latter table that in the intervals extending from 126 to 200 days after vaccination with the formolized preparations, immunity still persisted, although somewhat reduced in degree following an intracerebral test but yet fairly solid after the subcutaneous or intranasal tests for induced resistance. When compared with the protection conferred by active virus over prolonged periods of time, from 185 to 240 days after vaccination (Table IV) , the results point to the fact that while animals immunized with untreated virus withstand the intracerebral test for resistance to a higher degree, there is no significant difference between untreated and formolized virus vaccines in their respective capacities to induce protection against nasal or subcutaneous experimental infection--infection more closely simulating what occurs in nature--during the period of time studied.
Stability of Antigenic Power.--The antigenic stability of the formolized preparations is well illustrated in the records of vaccines III and XI (Table I) . They retained their immunizing property after storage at 5°C. for 63 and 65 days respectively.
In both materials the formalin was not neutralized by ammonium hydroxide until just before animal inoculation. By way of contrast, vaccine IV, neutralized just after inactivation by formalin had been completed, rapidly lost its capacity to immunize (Table II) .
Relation of Dose and Dilution of Vaccines to Induced Immunity.~
The results thus far tabulated consistently show a relation of the dose Abbreviations as in Table I . * Only one animal of a series survived intercurrent infections during the period prior to the immunity test.
of a vaccine to the immunity induced in guinea pigs. Consequently two injections, each of 1 cc., are practical for immunization. The relation of quantity is again brought out in experiments on mice, summarized in Table V . Undiluted preparations yielded complete, whereas 10 -1 dilution, little or no protection, and still greater dilutions none. 
Comparison of Formolized and Untreated, Active Virus
A comparison was now attempted with formolized virus on the one hand and with active virus on the other, on the respective degrees of immunity developed in mice and guinea pigs. As a corollary, the test of adding small, known amounts of virus to ineffective, formolized tissue was performed to determine whether such virus was antigenic since, as has been shown (5), these small quantities were not immunizing by themselves.
Tests with the
Mouse.--The optimal dosage of active virus needed to protect guinea pigs uniformly against 1,000 ~.L.D. given by way of the brain has already been defined in a foregoing section. Similarly to build up resistance in mice regularly against twenty to fifty intracerebral lethal doses, 600 to 6,000 m.i.u. of virus given intraperitoneally twice at 7 days' interval are required. But, as shown in Table V , such amounts of active virus, although the optimum for immunization, are dangerous to the mouse, since of ten animals receiving this treatment, two succumbed to virus infection. Even subliminal quantities produced fatal infection. On the other hand, solid resistance was obtained witfi safety by the use of the adequate dose of formolized vaccine, in which it was not possible to detect active virus (Table V) . Tables VI and VII summarize the results of a large number of experiments on comparison of active virus, as such, and formolized vaccines as immunizing materials. It is clear that guinea pigs were rendered resistant to as many as 1,000 intracerebral lethal doses by means of formolized vaccines in which it was impossible to demonstrate the presence of active virus. It is equally plain that to obtain the same degree of resistance by means of active virus itself, it was found necessary to inject subcutaneously 3,000 to 30,000 m.i.u, three times at 7 days' interval.
Tests with the Guinea Pig.--
Forty guinea pigs resisted an intracerebral test of over 1,000 M.L.I). 17 to 99 days after immunization with formolized virus was begun. Thirty-seven of them withstood a repeated, similar intracerebral test 14 to 90 days following the first test, and all of six were protected against a third intracerebral dose of over 1,000 M.L.D. given 78 days after the second test (or 128 days after vaccination was begun).
Effect of Minute Amounts of Virus Added to Formolized
Tissue.--The object of this experiment was to determine whether minute amounts of virus in the presence of large amounts of formolized tissue may be antigenic, when either by itself was non-immunizing.
Vaccine XIII was stored at 5°C. for 6 months. At the end of this time, no active virus could be demonstrated in it by inoculation of either tissue cultures or mice. To formalin-neutralized portions of the material were added known quantities of active virus and guinea pigs were injected subcutaneously with the mixtures. The presence of active virus in the mixtures was manifested by inoculation of tissue cultures and mice. The experiment is summarized in Table VIII and reveals that ineffective formolized material was still inert when Table I. known quantities of active mouse passage virus were added. Resistance to test doses was induced only when the amounts of active virus added approached the adequate dosage (5) as shown in Tables VI and VII. (Table II, vaccine XIII).
The somewhat better results exhibited by 300 to 1,500 units of virus added to vaccine over the same mount of virus in broth may be ascribed to summation effect of two substances which, when used separately, had only little effect (Table VIII) .
Thus, large amounts of tissue do not activate small amounts of virus to become antigenic.
The three groups of experiments included in this section yielded results which are in agreement with each other and focus to the point that the virus, inactivated by formalin, still retains the capacity of inducing immunity. The degree of resistance produced by formolized virus is similar to that developed by untreated active virus and the protection conferred is not due to residual virus which may possibly be present in the vaccines. 4
Recapitulation
Before discussing the experimental results, a summary of this study is indicated.
Guinea pigs can be rendered resistant to as many as 1,000 intracerebral lethal doses by the use of suitable preparations of virus which have been, in a practical sense, wholly inactivated by the addition of formalin. Suitable preparations are those made with tissue which is non-glycerolated and has a high content of virus before formolization, and in which the chemical is not neutralized until just before use in animals. These conditions have been disclosed thus far by the present experiments but the future may yet reveal other refinements in technique. The vaccines so prepared hold their antigenicity after storing for over 2 months. Not only guinea pigs but mice as well can be rendered immune by means of formolized virus.
The induced resistance is increased or diminished depending on the amount of the material given. The optimal dose for guinea pigs is two subcutaneous injections of 1 cc. each spaced about a week apart and for mice, 0.5 cc. subcutaneously or intraperitoneally at the same interval.
To obtain the same degree of protection by use of untreated active virus, it is necessary to inject guinea pigs subcutaneously with 3,000 to 30,000 mouse intracerebral units of virus three times at 7 days' * A study on passive immunity (i.e., antiviral bodies produced in guinea pigs by preparations containing active and inactivated virus) will be the subject of another communication. Although such bodies were found in both instances, the technical difificulties of their demonstration require an account too lengthy for this paper.
interval, and mice with 500 to 6,000 units, twice at the same periods of time. On comparison of the duration of induced resistance brought about by formolized, inactivated virus and by untreated active virus, one finds that the protection is as solid in the one as in the other within a period of about 3 months after vaccination. During longer periods, that is, from 3 to about 7 months (the longest time thus far studied), the resistance of the animals treated with formolized vaccine is somewhat lessened against an intracerebral test as compared with that developed in animals given untreated virus but the protection against intranasal and subcutaneous test inoculation is still apparently as staunch in the first group as in the second. It should be noted, however, that the resistance conferred by active virus is not in itself absolutely solid (see Table IV , for example, which reveals that three of sixteen animals succumbed to an intracerebral, and one of four to an intranasal test, 185 to 240 days after vaccination).
Finally, small amounts of virus are not activated by large amounts of inactive, formolized tissue. This factor, taken together with other experimental findings, points to the fact that the immunity produced by the inactivated vaccines is not dependent on the presence in them of possible residual active virus.
DISCUSSION
This paper concerns itself with a study, by quantitative methods, of (a) the immunization of guinea pigs and mice with inactivated, formolized virus of equine encephalomyelitis and (b) certain phases of the mechanism underlying the development of this induced resistance.
The materials of the immunizing preparation are mouse or guinea pig passage virus treated with formalin and by rigorous tests, made as complete as is possible, found to be free from active virus. If minute amounts of active virus may have been missed by means of the methods employed for its detection, such quantities by themselves, or deliberately added to ineffective formolized tissue, fail to give rise to protection. In other words, the protection is produced by some other means than minute amounts of virus possibly residual in the vaccines.
Why such formolized preparations should be effective for immunization is not definitely known. Yet light may be thrown on the problem by reference to experiments here described and to the recorded findings with other viruses.
In a test already mentioned, part of some fresh, infected brain was immersed in glycerol and part in formalin. The formotized fresh material proved antigenic; the formolized glycerolated substance, non-immunizing. If the assumption is made that the virus content of both portions of the brain was equal before chemical treatment, it follows that formalin itself has the particular property of preserving the antigenic complex, while glycerol has not.
Again, evidence is at hand which indicates that the power of inactivated, formolized virus to immunize depends on the high virus content of the tissues with which the vaccines are made. While this factor is also noted in canine distemper (11) and Rift Valley fever (12) viruses, it is not generally applicable, since negative or inconclusive results have been reported for the antigenicity of formolized vaccinia (13) and yellow fever (14) viruses. Yet the latter two agents can be diluted as high as 10 -7 and 10 -~ and still be infective in susceptible animals. On the other hand, Bedson (15) protected guinea pigs with inactivated, formolized herpes virus vaccines made from tissues infective, before formolization, in limiting dilutions as low as 10 -3 or 10 -4. Bedson also found that while inactivated material induced immunity, 10 M.I.D. of active herpes virus were ineffective.
It is of interest, furthermore, that when formolized vaccines are neutralized with ammonium hydroxide before storage, their antigenicity is rapidly lost. However this may be, vaccines kept in contact with formalin over long periods of time retain their immunizing capacity. Our results confirm the findings of Shahan and Giltner (16) on this point: Unneutralized vaccines were still effective after storage in the cold for at least 65 days. A similar stability has been noted with formoUzed Rift Valley fever (12) and dog distemper (11) viruses. 6 Bedson observed (15) that formolized herpes material is more resistant to steaming than active virus. The encephalomyelitis virus apparently differs in this respect. Forty mice in five groups of eight each were treated as follows: Mice of group I received formolized vaccine; those of group II, the same, steamed 30 minutes; group III, the same steamed 60 minutes. Mice of group IV received active virus steamed 30 minutes and group V the same steamed 60 minutes. The same virus sample entered into the preparation of both materials employed in the five groups. 10 days later, all animals were given an intracerebral test with > 10 < 50 ~.L.9. and only the mice of group I (formolized vaccine, not steamed) resisted the test; all mice of the other groups succumbed to fatal encephalitis.
On another point of comparison with other viruses: Laidlaw and Dunkin (11) record that vaccines prepared from distemper tissues of dogs are of little value for immunizing ferrets and similarly for ferret tissue in dogs. They believe that the lessened response to heterologous vaccines may be due to the clogging of the antibody mechanism of the recipients with multiple antigens. Shahan and Giltner (16) state that guinea pigs are usually more solidly protected against an intracerebral test by means of homologous encephalomyelitis tissue than with horse material. In our hands, both fresh mouse and guinea pig brain after formolization proved equally effective as antigens.
Since now and again one or another point is found which coincides with that existing in other formolized viruses used in preventive inoculations, and since others are widely separated, it is necessary to emphasize that the findings here reported on the encephalomyelitis virus do not necessarily apply to other viruses.
We leave now the discussion of the theoretical aspects of the problem to consider certain practical bases on which the formolized vaccine might be used in actual field immunization, especially in places where the disease is enzootic.
It has been shown that the degree of induced resistance is in proportion to the quantity of vaccine given. Yet, no experimental evidence can be adduced from the total amounts of material inoculated--in mice 0.5 to 1.0 cc., in guinea pigs, 2 cc., and in horses (16) , 50 cc.--that there is a body weight/quantity of inoculum ratio required for successful immunization.
Again, experimental and epidemiological findings indicate that equine encephalomyelitis is a blood-borne infection that is transmitted by insect vectors. It is plain that a method of immunization by means of active virus is not without danger of setting up loci of infection and spread of the disease. From the work of Shahan and Giltner (7, 16) and our own, we believe that by the use of inactivated, formolized vaccines, the danger of circulation of virus or of infection during immunization is removed and that such material might render horses resistant to the natural disease for a period of time sufficiently long to be of practical value. 6 CONCLUSION From a study by quantitative methods, the conclusion is reached that a resistance of high degree may be induced in guinea pigs and mice against experimental equine encephalomyelitis by means of formolized vaccines in which no active virus can be demonstrated. The induced resistance is not due to residual traces of active virus which might possibly have escaped detection in the formolized tissue preparations.
